Blueprint Medicines Competitors and Similar CompaniesClear all

Halozyme Therapeutics's competitors and similar companies include Repare Therapeutics, Ohm Oncology and AstraZeneca United States.
Halozyme Therapeutics
Halozyme Therapeutics
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
Repare Therapeutics
Repare Therapeutics
Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.
Ohm Oncology
Ohm Oncology
Ohm Oncology is a drug development company committed to treating drug-resistant neoplasms and cancers with multi-mechanism compounds.
AstraZeneca United States
AstraZeneca United States
AstraZeneca United States is a biopharmaceutical company.
Founding Date
Founding Date
1998
Founding Date
2016
Founding Date
2015
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Private
Type
Subsidiary
Tags
Locations
Locations
San Diego, US HQ
Locations
Montréal, CA HQ
Cambridge, US
Locations
Austin, US HQ
Locations
Wilmington, US HQ
Gaithersburg, US
Employees
Employees
373157% increase
Employees
1791% decrease
Employees
167% decrease
Employees
N/A
Valuation ($)
Valuation ($)
5.2 b
Valuation ($)
173.4 m
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
423
Twitter followers
1 k
Twitter followers
N/A
Twitter followers
83.4 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
5
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.6
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
88.89%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
80%

Financial

Revenue (est.)
Revenue (est.)
$829.3m (FY, 2023)
Revenue (est.)
$135k (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$192.4m (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$636.9m (FY, 2023)
Gross profit
$135k (FY, 2020)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
$281.6m (FY, 2023)
Net income
($53.4m) (FY, 2020)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 171.9m
Total funding raised
$ 150.5m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Repare Therapeutics
HQ
Montréal, CA
Employees
179↓ 1% decrease

Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.

View company
Ohm Oncology
HQ
Austin, US
Employees
1

Ohm Oncology is a drug development company committed to treating drug-resistant neoplasms and cancers with multi-mechanism compounds.

View company
AstraZeneca United States
HQ
Wilmington, US

AstraZeneca United States is a biopharmaceutical company.

View company